Article
Riboflavin lowers blood pressure in cardiovascular disease patients homozygous for the 677C→T polymorphism in MTHFR
13 Feb 2010
Abstract excerpt
OBJECTIVE: The purpose was to examine the effect of intervention with riboflavin (a cofactor for MTHFR) on blood pressure in patients homozygous (TT genotype) for the common 677C-->T polymorphism in MTHFR. METHODS: We investigated 197 premature cardiovascular disease patients, prescreened for the MTHFR 677C-->T polymorphism, from an original cohort of 404 to select those with the TT genotype (n = 60) and a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
